Myocardial post-conditioning with Danshen-Gegen decoction protects against isoproterenol-induced myocardial injury via a PKCε/mKATP-mediated pathway in rats

Chinese Medicine

Volumn 6, Issue , 2011, Pages

  Wong, Sze M ^a   Chiu, Po Y ^a   Leung, Hoi Y ^a   Zhou, Limin ^b   Zuo, Zhong ^b   Lam, Philip Y ^a   Ko, Kam M ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ION; CHINESE DRUG; CYTOCHROME C; DANSHEN GEGEN; GLUTATHIONE; ISOPRENALINE; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; LIPID PEROXIDATION; MITOCHONDRION; NONHUMAN; PROTEIN TRANSPORT; RAT;

EID: 79851514411     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-6-7     Document Type: Article

References (45)

1. Klevay LM. Ischemic heart disease as deficiency disease. Cell Mol Biol (Noisy-le-grand) 2004, 50:877-884.
2. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet 2003, 361:847-858. 10.1016/S0140-6736(03)12712-2, 12642064.
3. Harris HA. Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential. Ernst Schering Found Symp Proc 2006, 1:149-161. full_text, 17824176.
4. Xu YY, Wan RZ, Lin YP, Yang L, Chen Y, Liu CX. Recent advance on research and application of Salvia miltiorrhiza. Asian J Pharmacodyn Pharmacokinet 2007, 7:99-130.
5. Sieveking DP, Woo KS, Fung KP, Lundman P, Nakhla S, Celermajer DS. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. Int J Cardiol 2005, 105:40-45. 10.1016/j.ijcard.2004.10.052, 16207543.
6. Ren JS, Luo XH. A review on the combination uses of Gegen and Danshen in traditional Chinese medicine. Shanxi Zhongyi Xueyuan Xuebao 2006, 7:51-52.
7. Tam WY, Chook P, Qiao M, Chan LT, Chan TY, Poon YK, Fung KP, Leung PC, Woo KS. The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. J Altern Complement Med 2009, 15:415-421. 10.1089/acm.2008.0400, 19388864.
8. Wu L, Qiao H, Li Y, Li L. Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytomedicine 2007, 14:652-658. 10.1016/j.phymed.2007.07.060, 17870452.
9. Chiu PY, Wong SM, Leung HY, Leong PK, Chen N, Zhou LM, Zuo Z, Lam PY, KM K. Long-term treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKC/mKATP pathway in rats. Rejuven Res 2011,
10. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?. J Mol Cell Cardiol 2009, 47:32-40. 10.1016/j.yjmcc.2009.03.019, 19344728.
11. Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL. Regulating RISK: a role for JAK-STAT signaling in post-conditioning?. Am J Physiol Heart Circ Physiol 2008, 295:H1649-H1656. 10.1152/ajpheart.00692.2008, 2593522, 18708442.
12. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919. 10.1161/CIRCULATIONAHA.108.805242, 18981312.
13. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic pre-conditioning and post-conditioning. Trends Cardiovasc Med 2005, 15:69-75. 10.1016/j.tcm.2005.03.001, 15885573.
14. Hausenloy DJ, Lecour S, Yellon DM. Reperfusion injury salvage kinase and survivor activating factor enhancement pro-survival signalling pathways in ischaemic post-conditioning: Two sides of the same coin. Antioxid Redox Signal 2011, 14:693-907.
15. Pagliaro P, Penna C. Cardiac Post-conditioning. Antioxid Redox Signal 2011, 14:777-779. 10.1089/ars.2010.3531, 20712411.
16. Lacerda L, Somers S, Opie LH, Lecour S. Ischaemic post-conditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 2009, 84:201-208. 10.1093/cvr/cvp274, 19666677.
17. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR, Rios M, Roffler-Tarlov S, Chikaraishi DM. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 2003, 284:H2069-H2077.
18. Mohan M, Patankar P, Ghadi P, Kasture S. Cardioprotective potential of Punica granatum extract in isoproterenol-induced myocardial infraction in Wistar rats. J Pharmacol Pharmacother 2010, 1:32-37.
19. Nandave M, Mohanty I, Nag TC, Ojha SK, Mittal R, Kamari S, Arya DS. Cardioprotective response to chronic administration of vitamin E in isoproterenol induced myocardial necrosis: hemodynamic, biochemical and ultrastructural studies. Indian J Clin Biochem 2007, 22:22-28.
20. Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur J Pharmacol 2008, 586:244-250. 10.1016/j.ejphar.2008.02.057, 18384769.
21. Nivethetha M, Jayasri J, Brindha P. Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. Singapore Med J 2009, 50:300-302.
22. Chinese Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China. Part I 2005, Beijing: Chemical Industry Press, Chinese Pharmacopoeia Committee.
23. Chang Q, Sun L, Zhao RH, Chow MS, Zuo Z. Simultaneous determination of ten active components in traditional Chinese medicinal products containing both Gegen (Pueraria lobata) and Danshen (Salvia miltiorrhiza) by high-performance liquid chromatography. Phytochem Anal 2008, 19:368-375. 10.1002/pca.1063, 18438756.
24. Panda VS, Nail SR. Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluation. Exp Toxicol Pathol 2008, 60:397-404. 10.1016/j.etp.2008.03.010, 18513933.
25. Vanderlinde RE. Measurement of total lactate dehydrogenase activity. Ann Clin Lab Sci 1985, 15:13-31.
26. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980, 106:207-212. 10.1016/0003-2697(80)90139-6, 7416462.
27. Cheng GW, Wu HL, Huang YL. Simultaneous determination of malondialdehyde and ofloxacin in plasma using an isocratic high-performance liquid chromatography/fluorescence detection system. Anal Chim Acta 2008, 616:230-234. 10.1016/j.aca.2008.04.012, 18482608.
28. Chiu PY, Ko KM. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. Biofactors 2003, 19:43-51. 10.1002/biof.5520190106, 14757976.
29. Popova T, Pinheiro de Carvalho MA, Matasova L, Medvedeva L. Regulation of mitochondrial NADP-isocitrate dehydrogenase in rat heart during ischemia. Mol Cell Biochem 2007, 294:97-105. 10.1007/s11010-006-9249-9, 16823514.
30. Menze MA, Hutchinson K, Laborde SM, Hand SC. Mitochondrial permeability transition in the crustacean Artemia franciscana: absence of a calcium-regulated pore in the face of profound calcium storage. Am J Physiol Regul Integr Comp Physiol 2005, 289:R68-R76.
31. Kavazis AN, McClung JM, Hood DA, Powers SK. Exercise induces a cardiac mitochondrial phenotype that resists apoptotic stimuli. Am J Physiol Heart Circ Physiol 2008, 294:H928-H935. 10.1152/ajpheart.01231.2007, 18083894.
32. Senthil S, Sridevi M, Pugalendi KV. Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol 2007, 35:418-423. 10.1080/01926230701230312, 17455091.
33. Lash LH. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact 2006, 163:54-67. 10.1016/j.cbi.2006.03.001, 1621086, 16600197.
34. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287:C817-C833. 10.1152/ajpcell.00139.2004, 15355853.
35. Armstrong JS, Whiteman M, Rose P, Jones DP. The Coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition: role of mitochondrial complex III. J Biol Chem 2003, 278:49079-49084. 10.1074/jbc.M307841200, 12949071.
36. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001, 495:12-15. 10.1016/S0014-5793(01)02316-X, 11322939.
37. Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM, Hung CC. Lipid peroxidation: a possilbe role in the induction and progression of chronic periodontitis. J Periodont Res 2005, 40:378-384. 10.1111/j.1600-0765.2005.00818.x, 16105090.
38. Dukhande VV, Isaac AO, Chatterji T, Lai JC. Reduced glutathione regenerating enzymes undergo developmental decline and sexual dimorphism in the rat cerebral cortex. Brain Res 2009, 1286:19-24. 10.1016/j.brainres.2009.05.029, 19450567.
39. Gorin MA, Pan Q. Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer 2009, 8:9-16. 10.1186/1476-4598-8-9, 2647895, 19228372.
40. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 2008, 120:172-185. 10.1016/j.pharmthera.2008.08.002, 18786563.
41. Rojo AI, Sagarra MR, Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 2008, 105:192-202. 10.1111/j.1471-4159.2007.05124.x, 18005231.
42. Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol 2006, 291:H827-H834. 10.1152/ajpheart.00003.2006, 16517948.
43. Gao Q, Yang B, Ye ZG, Wang J, Bruce IC, Xia Q. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur J Pharmacol 2007, 574:179-184. 10.1016/j.ejphar.2007.07.018, 17692311.
44. Cao CM, Xia Q, Gao Q, Chen M, Wong TM. Calcium-activated potassium channel triggers cardioprotection of ischemic pre-conditioning. J Pharmacol Exp Ther 2005, 312:644-650. 10.1124/jpet.104.074476, 15345753.
45. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001, 38:307-314. 10.1016/S0735-1097(01)01377-8, 11499717.